Management Business

It is heart-breaking when we see people with rare and common diseases and they just could not get the medication that they need either because of financial inability or because the treatment that can release them from the disease is just not available. When it comes to age-related macular degeneration, which is the leading cause of blindness in Americans over 60 years of age, The Advance Cell Technology, Inc. is developing a way out. As a CEO with three decades of experience in technology and management, William M. Caldwell IV is leading Advance Cell Technology, Inc in giving millions of patients around the world the regenerative medicine to bring the effective treatment for curing AMD. It becomes a new hope for people with AMD. Senior citizens with AMD experience disorder in their vision. As they age, they lost sharp and central vision gradually and AMD makes it even worse.

Having AMD makes even the simple activities become very difficult to perform. This is a sad condition and the regenerative medicine that is being developed by the Advance Cell Technology, Inc is giving a new hope for them. The company applies the stem cell-based technology and gives the effective treatment for the patients to undergo. With the expertise of William M. Caldwell in running a company, Advance Cell Technology, Inc has been growing bigger and stronger. They are currently focused in three product areas. One of them is the retinal pigment epithelium program. This is a new therapy for treating AMD. The company, together with Casey Eye Institute at OHSU just announced the results of a successful study around the long-term safety and the efficacy of the Retinal Disease Therapy developed by Advance Cell Technology, Inc.